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Traditional view considers that the arterial wall is composed of three concentric tissue coats (tunicae): intima, media, and 
adventitia. However, large- and medium-sized arteries, where usually atherosclerosis develops, are consistently surrounded 
by periadventitial adipose tissue (PAAT). Here we update growing information about PAAT, and conceptualize it as the 
fourth coat of  arterial wall, that is, tunica adiposa (in brief, adiposa, like intima, media, adventitia). Recent evidence has 
revealed that adipose tissue expresses not only metabolic, but also secretory (endo- and paracrine) phenotype, producing/
releasing a large number of signaling proteins collectively termed adipokines. Through paracrine (“vasocrine”) way, 
adiposa-derived mediators may contribute to various arterial functions such as contraction-relaxation, smooth muscle 
cell growth, inflammation, hemostasis, and innervation, hence to “outside-in” signaling pathway of atherogenesis. 
Biomed Rev 2009; 20: 41–44.
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WE DANCE ROUND IN A RING AND SUPPOSE,
BUT THE SECRET SITS IN THE MIDDLE AND KNOWS.
ROBERT FROST
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INTRODUcTION 
In 1983 at Department of Anatomy, University of Chicago 
Medical School, Chicago, IL, USA, one of us (GNC) 
delivered a lecture about fibroblast-like secretion by vascular 
smooth muscle cells, a key cell type in atherogenesis. During 
the discussion, a question whether adventitial fibroblasts may 
migrate into the intima was raised. The answer of the lecturer 
was “I do not know. It seems impossible”. However, what 
seemed “impossible” in 1983 was proven possible in 1996 
by Shi et al (1).
The road less traveled (2) 
The prevailing response-to-injury hypothesis of Russell Ross 
states that atherosclerosis is an inflammatory disease, leading 
to intimal lesions and luminal loss in large- and medium-
sized arteries (3). Accordingly, intima-media thickness 
became an accepted measure of structural arterial remodeling 
and a strong predictor of atherosclerosis. However, it is 
unlikely that such one-direction road may solely travel the 
whole multiplex network like that of atherogenesis. Almost 
a decade ago, we have proposed an “interactive hypothesis” 
of atherogenesis, which appreciated the role of all structural 
components of the artery wall including periadventitial 
adipose tissue (PAAT) (4-6). 
A long standing paradigm holds that the artery wall consists 
of three concentric tissue coats (tunicae): intima, media, and 
adventitia. However, large- and medium-sized blood vessels 
(where usually atherosclerosis develops) are consistently 
enveloped by PAAT, herein referred to as tunica adiposa (Fig. 
1).  Recent evidence has revealed that the adipose tissue is a 
dynamic endocrine and paracrine organ producing more than 
100 signaling proteins, collectively termed adipokines (4,7-
16),  abundantly secreted by inflamed and hypoxic adipose 
tissue (12,13,15). Adiposa-derived mediators may contribute 
to vascular tone (17-19), inflammation (12,13,15,16) smooth 
muscle cell growth (14), hemostasis and vascular wound 
healing (reviewed in 20,21).
Given the key role of inflammation in the development 
of atherosclerotic lesions, what role might tunica adiposa 
play in the process of atherogenesis? For instance, it is 
Figure 1. Schematic presentation of vascular wall composed of four tissue coats (tunicae):  intima, media, adventitia, and 
adiposa. Arrows show that tunica media is a target for at least two vasorelaxing factors, endothelium-derived relaxing factor 
(EDRF) and adipocyte-derived relaxing factor (ADRF), respectively. Modified from reference 20.  
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know that the proximal segments of coronary arteries are 
surrounded by subepicardial adipose tissue, and these 
segments are atherosclerosis-prone as compared to the 
distal, intramyocardial, tunica adiposa-free segments, which 
are atherosclerosis-resistant (4-6). Moreover, the evidence 
that the growth of adipose tissue mass is associated with 
tissue hypoxia (16) and, consequently, an accumulation of 
macrophages and T-lymphocytes, has raised the hypothesis 
that the inflamed adipose tissue is a primary event involved 
in the genesis of systemic and local (also vascular) disorders 
(15). Note that both external and internal fat accumulation 
(22) is associated with an imbalanced secretion represented 
by a decreased release of antiinflammatory adipokines (13) 
and an enhanced release of proinflammatory adipokines 
(12,15) (Table 1). Such an friend-or-enemy (good cop-or-bad 
cop, as Americans used to say) secretory capacity of tunica 
adiposa requires specific pharmacological manipulation, 
aiming at boosting the production and/or receptor sensitivity 
of antiinflammatory adipokines (13,20), also vasorelaxing 
factors (17,18). 
Cumulatively, adipobiology might be a new filed in 
vascular medicine. Hence (i) in basic research, we should 
no longer cut tunica adiposa, but keep it attached and in 
place, and subject to thorough examination, (ii) not only 
intima-media and epicardial adipose tissue thickness, but 
also adiposa thickness should be imaged, for example, in 
identifying high-risk population susceptible to atherosclerosis 
and monitor vascular wall changes during follow-up studies 
and therapeutic trials, (iii) adiposa may represent a new 
therapeutic target for vascular diseases, and (iv) structure-
based mathematical models for arterial remodeling should 
also consider the forth arterial coat.
cONcLUSION
Here we have spotlighted an adipose road of atherogenesis, 
focusing on the possible paracrine role of tunica adiposa in 
an “outside-in” signaling pathway.
“And that has made some difference”, paraphrasing Robert 
Frost’s The road not taken (2).
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Table 1. A selected list of adipose tissue-derived mediators, 
as related to atherosclerosis and hypertension
Antiinflammatory adipokines





Leptin, IL-1, IL-6, IL-17, IL-18, IL-33, TNF-α, CRP, 
resistin, visfatin, vaspin, MIP-1 (CCL2), IL-8 (CXCL8), 
fractalkine (CX3CL1), RANTES, hepcidin, substance P, 
homocysteine**
Vasodilators
Adipocyte-derived relaxing factor, nitric oxide (NO), 
hydrogen sulfide (H2S), adiponectin, cardiac natriuretic 
peptide, adrenomedullin
Vasoconstrictors
Superoxide anion, angiotensin II, endothelin-1
Hemostasis-related factors
Plasminogen activator inhibitor-1, tissue factor
Abbreviations: IL, interleukin; NGF, nerve growth factor; 
BDNF, brain-derived neurotrophic factor; CNTF, ciliary 
neurotrophic factors; TNF-α, tumor necrosis factor-
alpha; CRP, C-reactive protein; MIP-1 (CCL2), monocyte 
chemoattractant protein MIP-1 (Cysteine-Cysteine modif 
chemokine Ligand 2); RANTES, regulated on activated 
normal T-cell expressed and secreted.  Note, all components 
of renin-angiotensin system are also expressed in PAAT 
(7,19), suggesting a role in the development of  hypertension. 
* NGF, BDNF and CNTF are not only for nerves, but they 
also improve glucose, lipid and energy homeostasis (20,21).
** Hyperhomocysteinemia is in the list of global 
cardiometabolic risks. This sulfur-containing aminoacid 
deriving from the methionine metabolism may also be 
consider “adipokine” - all enzymes involved in the synthesis 
and metabolism of homocyteine are expressed in adipose 
tissue (23).
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